The grant will fund additional patient dosing studies to identify predictive biomarkers of activity and target engagement of TRE-515 in solid tumors. Treth...
$7.5M Pre-Series A financing led by new investor MP Healthcare, the venture arm of Mitsubishi Tanabe Pharma Group. Existing investors Cambridge Enterpris...
DF-006 is a first-in-class, orally administered ALPK1 agonist immunomodulator that potently stimulates local, innate immunity in the liver, leading to a ro...
Cascade Health, an intelligent platform for healthcare transparency, announced it has raised $1.7 million in venture funding led by AlleyCorp with particip...
-Lavita AI, a next generation AI+Web3 healthcare platform, announced today it has closed a $5M seed financing round, led by Camford Capital, and angel inve...
The life science track includes companies developing technology in the fields of drug discovery, pharmaceuticals, and therapeutics. The medical technologie...
The proposed non-clinical studies will investigate pharmacodynamic biomarkers for ST316, a first-in-class β-catenin antagonist, and evaluate the impac...
An accomplished leader, David joins Amplify Health from Optum, part of UnitedHealth Group, where he was most recently Vice President, Enterprise Data and A...
GSK4532990 is being developed under the November 2021 exclusive license agreement between Arrowhead and GSK. GSK received an exclusive license to develop a...
-Labviva, the AI-driven life sciences digital marketplace that simplifies and scales purchasing processes, announced today that it has secured $20 million ...
© 2024 Biopharma Boardroom. All Rights Reserved.
